Salicyluric Acid

Salicyluric Acid

SCHEMBL2496831

O=C(O)CNC(=O)c1ccccc1O.O=c1[nH]c2[nH]c(=O)n(Cc3ccccc3O)c(=O)c2[nH]1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 4/20 0.39
EGLN3 Q9H6Z9 4/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 4/20 0.38
GLA P06280 1/20 0.37
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NLRP1 Q9C000 1/20 0.37
KEAP1 Q14145 1/20 0.35
PSMD14 O00487 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
EGLN2 Q96KS0 1/20 0.35
FTO Q9C0B1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL615555 0.84 MPO (0.38) MAPTALDH1A1MEN1KMT2AHPGD
Salicyluric Acid SCHEMBL29935452 0.71 HPGD (0.58) EGLN1MAPTALDH1A1MEN1KMT2A
Salicyluric Acid SCHEMBL570541 0.71 HPGD (0.58) EGLN1MAPTALDH1A1MEN1KMT2A
SCHEMBL6363070 0.70 ALDH1A1 (0.54) MAPTALDH1A1MEN1KMT2AHPGD
Iodohippurate SCHEMBL8073622 0.68 KEAP1 (0.42) EGLN1MEN1KMT2AKEAP1TDP1
SCHEMBL3389986 0.67 HPGD (0.57) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL3423457 0.67 EGLN1 (0.63) EGLN1EGLN3EGLN2
SCHEMBL4952951 0.66 LMNA (0.63) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18589492 0.63 LMNA (0.51)
SCHEMBL31448014 0.63 KEAP1 (0.62) EGLN1MAPTKMT2AKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664327-B1 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS AMERICAN DIAGNOSTICA INC (US) 2011-10-05 EP disclosed